Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) priced its public offering of 12,500,000 shares of its common stock at a public offering price of $4.17 per share. Shares of ARNA closed at $4.67 yesterday. All of the shares are being offered …
The Company intends to initiate a phase III program of Etrasimod in ulcerative colitis. ARNA closed Monday's trading at $30.89, down 1.97%. In after-hours, the stock was up 24.80% to $38.55. Apellis Pharmaceuticals Inc. (APLS) has a …
Most biotech stocks have recovered, at least to some extent, during the overall stock market’s most recent run to new highs. However, some haven’t. Wall Street has been betting heavily against Arena Pharmaceuticals (NASDAQ: ARNA). …
Arena Pharmaceuticals, Inc. (ARNA) was a big mover last session, as the company saw its shares rise by over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This …
On this news, the price of Arena common stock fell $2.72 per share, or nearly 40 percent, to close at $4.13 per share …
A live audio webcast of the presentations will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. In addition, Arena …
The project would be undertaken in collaboration with Israel-based farming solutions provider ARNA. Punjab Chief Minster Amarinder Singh today gave in- principle approval for the pilot project to provide affordable technical knowhow to the …
Final data readout from AlloJoin phase I clinical trial for off-the-shelf Knee Osteoarthritis (KOA) therapy in China in the first half of 2018. 2. Arena Pharmaceuticals Inc. (ARNA)
Arena Pharmaceuticals, Inc. ARNA reported a loss of 78 cents per share for the first ... Following the earnings release, Arena’s shares were down almost 3% on Tuesday. However, the stock has outperformed the industry so far this year.
Elan Corporation, plc (ADR) (NYSE:ELN) broke out today and traded nearly 2x normal daily volume. The stock has the potential to make a big run on Friday, so keep a close eye on ELN and don't miss the trade. From the technical …